NUWIQ
Antihemophilic Factor (Recombinant) · KIT · Octapharma USA Inc
Nuwiq is a recombinant antihemophilic factor used to treat hemophilia A by replacing the missing clotting factor VIII that people with this condition cannot produce naturally. It is administered by intravenous injection to help prevent and control bleeding episodes.
Key Facts
- Brand Name
- NUWIQ
- Generic Name
- Antihemophilic Factor (Recombinant)
- NDC Code (Product)
68982-145- Manufacturer
- Octapharma USA Inc
- Dosage Form
- KIT
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125555
- Marketing Start
- 01/01/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is NUWIQ used for?
Nuwiq is a recombinant antihemophilic factor used to treat hemophilia A by replacing the missing clotting factor VIII that people with this condition cannot produce naturally. It is administered by intravenous injection to help prevent and control bleeding episodes.
Is NUWIQ a controlled substance?
NUWIQ is not classified as a controlled substance by the DEA.
What is the generic name for NUWIQ?
The generic name for NUWIQ is Antihemophilic Factor (Recombinant). There are 11 other brand versions of Antihemophilic Factor (Recombinant).
What is the NDC code for NUWIQ ?
The NDC (National Drug Code) for NUWIQ is 68982-145, listed by Octapharma USA Inc.